Cargando…
Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
BACKGROUND: In spite of enhanced control efforts, malaria remains a major public health problem causing close to a million deaths annually. With support from several donors, large amounts of artemisinin-based combination therapy (ACT) are being deployed in endemic countries raising safety concerns a...
Autores principales: | Kuemmerle, Andrea, Dodoo, Alex NO, Olsson, Sten, Van Erps, Jan, Burri, Christian, Lalvani, Paul S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063823/ https://www.ncbi.nlm.nih.gov/pubmed/21388536 http://dx.doi.org/10.1186/1475-2875-10-57 |
Ejemplares similares
-
Artemisinin anti-malarial drugs in China
por: Guo, Zongru
Publicado: (2016) -
Editorial to the Feature article “Artemisinin anti-malarial drugs in China”
por: Zhang, Ao
Publicado: (2016) -
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study
por: Ndagije, Helen Byomire, et al.
Publicado: (2018) -
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases
por: Cheong, Dorothy H.J., et al.
Publicado: (2020) -
Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
por: Porter-Kelley, Johanna M, et al.
Publicado: (2010)